421 related articles for article (PubMed ID: 23170168)
1. Mouse models for filovirus infections.
Bradfute SB; Warfield KL; Bray M
Viruses; 2012 Sep; 4(9):1477-508. PubMed ID: 23170168
[TBL] [Abstract][Full Text] [Related]
2. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.
Martines RB; Ng DL; Greer PW; Rollin PE; Zaki SR
J Pathol; 2015 Jan; 235(2):153-74. PubMed ID: 25297522
[TBL] [Abstract][Full Text] [Related]
3. Animal models for filovirus infections.
Siragam V; Wong G; Qiu XG
Zool Res; 2018 Jan; 39(1):15-24. PubMed ID: 29511141
[TBL] [Abstract][Full Text] [Related]
4. Drug targets in infections with Ebola and Marburg viruses.
Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
[TBL] [Abstract][Full Text] [Related]
5. A small nonhuman primate model for filovirus-induced disease.
Carrion R; Ro Y; Hoosien K; Ticer A; Brasky K; de la Garza M; Mansfield K; Patterson JL
Virology; 2011 Nov; 420(2):117-24. PubMed ID: 21959017
[TBL] [Abstract][Full Text] [Related]
6. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
Geisbert TW; Strong JE; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.
Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Dong L; Garza NL; Donnelly G; Cazares LH; Nuss J; Soloveva V; Koistinen KA; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
Antiviral Res; 2018 Mar; 151():97-104. PubMed ID: 29289666
[TBL] [Abstract][Full Text] [Related]
8. The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis.
Feldmann H; Volchkov VE; Volchkova VA; Klenk HD
Arch Virol Suppl; 1999; 15():159-69. PubMed ID: 10470276
[TBL] [Abstract][Full Text] [Related]
9. Experimental Inoculation of Egyptian Rousette Bats (Rousettus aegyptiacus) with Viruses of the Ebolavirus and Marburgvirus Genera.
Jones ME; Schuh AJ; Amman BR; Sealy TK; Zaki SR; Nichol ST; Towner JS
Viruses; 2015 Jun; 7(7):3420-42. PubMed ID: 26120867
[TBL] [Abstract][Full Text] [Related]
10. The Baboon (Papio spp.) as a model of human Ebola virus infection.
Perry DL; Bollinger L; White GL
Viruses; 2012 Oct; 4(10):2400-16. PubMed ID: 23202470
[TBL] [Abstract][Full Text] [Related]
11. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
[TBL] [Abstract][Full Text] [Related]
12. Ebola and Marburg viruses: pathogenesis and development of countermeasures.
Hensley LE; Jones SM; Feldmann H; Jahrling PB; Geisbert TW
Curr Mol Med; 2005 Dec; 5(8):761-72. PubMed ID: 16375711
[TBL] [Abstract][Full Text] [Related]
13. Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice.
Lever MS; Piercy TJ; Steward JA; Eastaugh L; Smither SJ; Taylor C; Salguero FJ; Phillpotts RJ
J Med Microbiol; 2012 Jan; 61(Pt 1):8-15. PubMed ID: 21852521
[TBL] [Abstract][Full Text] [Related]
14. Prospects for immunisation against Marburg and Ebola viruses.
Geisbert TW; Bausch DG; Feldmann H
Rev Med Virol; 2010 Nov; 20(6):344-57. PubMed ID: 20658513
[TBL] [Abstract][Full Text] [Related]
15. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
16. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
Geisbert TW; Feldmann H
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1075-81. PubMed ID: 21987744
[TBL] [Abstract][Full Text] [Related]
17. Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.
Warfield KL; Olinger GG
J Biomed Biotechnol; 2011; 2011():984241. PubMed ID: 22253531
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of filoviral haemorrhagic fevers.
Mahanty S; Bray M
Lancet Infect Dis; 2004 Aug; 4(8):487-98. PubMed ID: 15288821
[TBL] [Abstract][Full Text] [Related]
19. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
Stock I
Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
[TBL] [Abstract][Full Text] [Related]
20. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
Suschak JJ; Schmaljohn CS
Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
